Terilyn J. Monroe - 07 Jan 2026 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Chief People Officer
Signature
/s/ John G. Saia, as attorney-in-fact for Tarilyn J. Monroe
Issuer symbol
GH
Transactions as of
07 Jan 2026
Net transactions value
-$1,124,279
Form type
4
Filing time
09 Jan 2026, 16:09:56 UTC
Previous filing
05 Jan 2026
Next filing
16 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Monroe Terilyn J. Chief People Officer 3100 HANOVER STREET, PALO ALTO /s/ John G. Saia, as attorney-in-fact for Tarilyn J. Monroe 09 Jan 2026 0001652956

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH Common Stock Sale $705,268 -6,311 -20% $111.75 24,710 07 Jan 2026 Direct F1
transaction GH Common Stock Sale $409,029 -3,632 -15% $112.62 21,078 07 Jan 2026 Direct F2
transaction GH Common Stock Sale $9,983 -88 -0.42% $113.44 20,990 07 Jan 2026 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $111.230 to $112.175. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
F2 Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $112.260 to $113.250. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
F3 Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $113.410 to $113.490. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.